Table 1. Basal characteristics and cerebrospinal fluid findings.
| Groups | p–value | ||
|---|---|---|---|
| NMO | Controls | ||
| Basal characteristics | |||
| Number | 26 | 23 | |
| Age at sampling (years) | 51.9 ± 7.4 (37.1 − 72.8) |
46.9 ± 15.9 (20 − 67.8) |
n.s. |
| Number of males (%) | 7 (27%) |
8 (35%) |
n.s. |
| Body mass index | 22.8 ± 2.7 (19 − 28.9) |
23.2 ± 2.7 (17.4 − 28.2) |
n.s. |
| Serum total cholesterol (mg/dL) | 187.2 ± 59.9 (65 − 320) |
168.8 ± 31.3 (110 − 225) |
n.s. |
| Serum glucose (mg/dL) | 121 ± 41 (77 − 158) |
94 ± 14.3 (78 − 113) |
n.s. |
| Cerebrospinal fluid study | |||
| White blood cell (cells /mm3) | 10.6 ± 17.7 (0 − 60) |
1.9 ± 6.3 (0 − 30) |
0.015 |
| Protein (mg/dL) | 42.1 ± 15.4 (20 − 80) |
35.5 ± 13.6 (21 − 80) |
n.s. |
| Glucose (mg/dL) | 64 ± 10.6 (44 − 88) |
62.7 ± 9.2 (42 − 81) |
n.s. |
| Albumin (mg/L) | 35.1 ± 22.6 (10.8 − 94.2) |
25.5 ± 15.8 (6.4 − 63.5) |
n.s. |
| IgG (mg/L) | 6.4 ± 5.2 (1.8 − 22) |
4.9 ± 3.7 (1.7 − 15.6) |
n.s. |